Highlights
The global Glutamate Carboxypeptidase 2 market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Glutamate Carboxypeptidase 2 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Glutamate Carboxypeptidase 2 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Glutamate Carboxypeptidase 2 include Cerecor Inc, Crescendo Biologics Ltd, Eisai Co Ltd and Inovio Pharmaceuticals Inc, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glutamate Carboxypeptidase 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glutamate Carboxypeptidase 2.
The Glutamate Carboxypeptidase 2 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Glutamate Carboxypeptidase 2 market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glutamate Carboxypeptidase 2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Cerecor Inc
Crescendo Biologics Ltd
Eisai Co Ltd
Inovio Pharmaceuticals Inc
Segment by Type
INO-5150
E-2072
Others
Segment by Application
Prostate Cancer
Neuropathic Pain
Congnitive Impairment
Glioblastoma Multiforme
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glutamate Carboxypeptidase 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glutamate Carboxypeptidase 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Glutamate Carboxypeptidase 2 Market Overview
1.1 Product Overview and Scope of Glutamate Carboxypeptidase 2
1.2 Glutamate Carboxypeptidase 2 Segment by Type
1.2.1 Global Glutamate Carboxypeptidase 2 Market Value Comparison by Type (2023-2029)
1.2.2 INO-5150
1.2.3 E-2072
1.2.4 Others
1.3 Glutamate Carboxypeptidase 2 Segment by Application
1.3.1 Global Glutamate Carboxypeptidase 2 Market Value by Application: (2023-2029)
1.3.2 Prostate Cancer
1.3.3 Neuropathic Pain
1.3.4 Congnitive Impairment
1.3.5 Glioblastoma Multiforme
1.3.6 Others
1.4 Global Glutamate Carboxypeptidase 2 Market Size Estimates and Forecasts
1.4.1 Global Glutamate Carboxypeptidase 2 Revenue 2018-2029
1.4.2 Global Glutamate Carboxypeptidase 2 Sales 2018-2029
1.4.3 Global Glutamate Carboxypeptidase 2 Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Glutamate Carboxypeptidase 2 Market Competition by Manufacturers
2.1 Global Glutamate Carboxypeptidase 2 Sales Market Share by Manufacturers (2018-2023)
2.2 Global Glutamate Carboxypeptidase 2 Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Glutamate Carboxypeptidase 2 Average Price by Manufacturers (2018-2023)
2.4 Global Glutamate Carboxypeptidase 2 Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Glutamate Carboxypeptidase 2, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glutamate Carboxypeptidase 2, Product Type & Application
2.7 Glutamate Carboxypeptidase 2 Market Competitive Situation and Trends
2.7.1 Glutamate Carboxypeptidase 2 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glutamate Carboxypeptidase 2 Players Market Share by Revenue
2.7.3 Global Glutamate Carboxypeptidase 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glutamate Carboxypeptidase 2 Retrospective Market Scenario by Region
3.1 Global Glutamate Carboxypeptidase 2 Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Glutamate Carboxypeptidase 2 Global Glutamate Carboxypeptidase 2 Sales by Region: 2018-2029
3.2.1 Global Glutamate Carboxypeptidase 2 Sales by Region: 2018-2023
3.2.2 Global Glutamate Carboxypeptidase 2 Sales by Region: 2024-2029
3.3 Global Glutamate Carboxypeptidase 2 Global Glutamate Carboxypeptidase 2 Revenue by Region: 2018-2029
3.3.1 Global Glutamate Carboxypeptidase 2 Revenue by Region: 2018-2023
3.3.2 Global Glutamate Carboxypeptidase 2 Revenue by Region: 2024-2029
3.4 North America Glutamate Carboxypeptidase 2 Market Facts & Figures by Country
3.4.1 North America Glutamate Carboxypeptidase 2 Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Glutamate Carboxypeptidase 2 Sales by Country (2018-2029)
3.4.3 North America Glutamate Carboxypeptidase 2 Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glutamate Carboxypeptidase 2 Market Facts & Figures by Country
3.5.1 Europe Glutamate Carboxypeptidase 2 Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Glutamate Carboxypeptidase 2 Sales by Country (2018-2029)
3.5.3 Europe Glutamate Carboxypeptidase 2 Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glutamate Carboxypeptidase 2 Market Facts & Figures by Country
3.6.1 Asia Pacific Glutamate Carboxypeptidase 2 Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Glutamate Carboxypeptidase 2 Sales by Country (2018-2029)
3.6.3 Asia Pacific Glutamate Carboxypeptidase 2 Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glutamate Carboxypeptidase 2 Market Facts & Figures by Country
3.7.1 Latin America Glutamate Carboxypeptidase 2 Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Glutamate Carboxypeptidase 2 Sales by Country (2018-2029)
3.7.3 Latin America Glutamate Carboxypeptidase 2 Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glutamate Carboxypeptidase 2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Glutamate Carboxypeptidase 2 Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Glutamate Carboxypeptidase 2 Sales by Country (2018-2029)
3.8.3 Middle East and Africa Glutamate Carboxypeptidase 2 Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glutamate Carboxypeptidase 2 Sales by Type (2018-2029)
4.1.1 Global Glutamate Carboxypeptidase 2 Sales by Type (2018-2023)
4.1.2 Global Glutamate Carboxypeptidase 2 Sales by Type (2024-2029)
4.1.3 Global Glutamate Carboxypeptidase 2 Sales Market Share by Type (2018-2029)
4.2 Global Glutamate Carboxypeptidase 2 Revenue by Type (2018-2029)
4.2.1 Global Glutamate Carboxypeptidase 2 Revenue by Type (2018-2023)
4.2.2 Global Glutamate Carboxypeptidase 2 Revenue by Type (2024-2029)
4.2.3 Global Glutamate Carboxypeptidase 2 Revenue Market Share by Type (2018-2029)
4.3 Global Glutamate Carboxypeptidase 2 Price by Type (2018-2029)
5 Segment by Application
5.1 Global Glutamate Carboxypeptidase 2 Sales by Application (2018-2029)
5.1.1 Global Glutamate Carboxypeptidase 2 Sales by Application (2018-2023)
5.1.2 Global Glutamate Carboxypeptidase 2 Sales by Application (2024-2029)
5.1.3 Global Glutamate Carboxypeptidase 2 Sales Market Share by Application (2018-2029)
5.2 Global Glutamate Carboxypeptidase 2 Revenue by Application (2018-2029)
5.2.1 Global Glutamate Carboxypeptidase 2 Revenue by Application (2018-2023)
5.2.2 Global Glutamate Carboxypeptidase 2 Revenue by Application (2024-2029)
5.2.3 Global Glutamate Carboxypeptidase 2 Revenue Market Share by Application (2018-2029)
5.3 Global Glutamate Carboxypeptidase 2 Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Cerecor Inc
6.1.1 Cerecor Inc Corporation Information
6.1.2 Cerecor Inc Description and Business Overview
6.1.3 Cerecor Inc Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Cerecor Inc Glutamate Carboxypeptidase 2 Product Portfolio
6.1.5 Cerecor Inc Recent Developments/Updates
6.2 Crescendo Biologics Ltd
6.2.1 Crescendo Biologics Ltd Corporation Information
6.2.2 Crescendo Biologics Ltd Description and Business Overview
6.2.3 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Product Portfolio
6.2.5 Crescendo Biologics Ltd Recent Developments/Updates
6.3 Eisai Co Ltd
6.3.1 Eisai Co Ltd Corporation Information
6.3.2 Eisai Co Ltd Description and Business Overview
6.3.3 Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eisai Co Ltd Glutamate Carboxypeptidase 2 Product Portfolio
6.3.5 Eisai Co Ltd Recent Developments/Updates
6.4 Inovio Pharmaceuticals Inc
6.4.1 Inovio Pharmaceuticals Inc Corporation Information
6.4.2 Inovio Pharmaceuticals Inc Description and Business Overview
6.4.3 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Product Portfolio
6.4.5 Inovio Pharmaceuticals Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glutamate Carboxypeptidase 2 Industry Chain Analysis
7.2 Glutamate Carboxypeptidase 2 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glutamate Carboxypeptidase 2 Production Mode & Process
7.4 Glutamate Carboxypeptidase 2 Sales and Marketing
7.4.1 Glutamate Carboxypeptidase 2 Sales Channels
7.4.2 Glutamate Carboxypeptidase 2 Distributors
7.5 Glutamate Carboxypeptidase 2 Customers
8 Glutamate Carboxypeptidase 2 Market Dynamics
8.1 Glutamate Carboxypeptidase 2 Industry Trends
8.2 Glutamate Carboxypeptidase 2 Market Drivers
8.3 Glutamate Carboxypeptidase 2 Market Challenges
8.4 Glutamate Carboxypeptidase 2 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Cerecor Inc
Crescendo Biologics Ltd
Eisai Co Ltd
Inovio Pharmaceuticals Inc
*If Applicable.